This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Japanese Small Bone & Joint Orthopedic Devices Market

NEW YORK, April 10, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Japanese Small Bone & Joint Orthopedic Devices Market http://www.reportlinker.com/p01158060/Japanese-Small-Bone--Joint-Orthopedic-Devices-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

In 2012, the total Japanese market for small bone and joint orthopedic devices was valued at $69.5 million.The Japanese small bone and joint orthopedic device market includes shoulder reconstruction implants, elbow repair devices, hand and wrist devices as well as foot and ankle devices. All of these segments experienced positive growth in 2012. An aging population continued to drive demand along with increased awareness regarding small bone and joint procedures. The overall market has been somewhat affected by reimbursements imposed by the Japanese government, which has influenced manufacturers to reduce their product prices. The success of large joint implants in Japan has caused surgeons and patients alike to become more comfortable with the prospect of small bone and joint replacement. Small bone and joint replacement product innovation has also improved efficacy. Overall, the strong positive growth in all segments will allow the entire market to grow rapidly over the 2012–2019 forecast period.

Scope:

This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.

Report Contents:

Competitor AnalysisIdentified Strategic OpportunitiesMarket Overview by Segment & CountryTrend Analysis by Segment & CountryMarket Drivers & LimitersMergers & AcquisitionsCustomer Feedback and Market Monitoring

Main Segments Included:

Shoulder Reconstruction MarketElbow Repair MarketHand &Wrist Device MarketFoot & Ankle Device Market

Sub-Segments Included:

Reversed-Shoulder ImplantsPartial Shoulder ImplantsResurfacing ImplantsShoulder RevisionPrimary Shoulder Implant MarketPartial Shoulder Implant MarketShoulder Resurfacing MarketPrimary Elbow DevicesRadial Head Elbow DevicesContraindicationsSemi-Constrained Total Elbow MarketUnconstrained Total Elbow MarketRadial Head Implant MarketWrist Fusion MarketDistal Radius Plate MarketFoot TreatmentsTotal Ankle Replacement MarketTotal Ankle Implant MarketFoot Digit Implant Market

Companies Included:

Medartis (ME System)DePuy SynthesUnitechZimmerTornierSmith & NephewSBiBiometAcumed (Japan Medicalnext)StrykerNakashima MedicalWright MedicalKyoceraArthrexExactech Lima

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "bottom up" approach, which includes primary and secondary research methods.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,947.95 +32.88 0.19%
S&P 500 1,966.82 +2.14 0.11%
NASDAQ 4,413.4610 +17.2570 0.39%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs